These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6338571)

  • 1. Meningococcal disease: still with us.
    Peltola H
    Rev Infect Dis; 1983; 5(1):71-91. PubMed ID: 6338571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meningococcal disease in Africa--epidemiology and prevention].
    Norheim G; Rosenqvist E; Aavitsland P; Caugant DA
    Tidsskr Nor Laegeforen; 2000 Jun; 120(15):1735-9. PubMed ID: 10904659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
    Pace D; Pollard AJ
    Arch Dis Child; 2007 Oct; 92(10):909-15. PubMed ID: 17895339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal disease in urban south western Sydney, 1990-1994.
    Munro R; Kociuba K; Jelfs J; Brown J; Crone S; Chant K
    Aust N Z J Med; 1996 Aug; 26(4):526-32. PubMed ID: 8873936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing protection against meningococcal disease.
    Reisinger KS; Black S; Stoddard JJ
    Clin Pediatr (Phila); 2010 Jun; 49(6):586-97. PubMed ID: 20089551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neisseria meningitidis B vaccines.
    Panatto D; Amicizia D; Lai PL; Gasparini R
    Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community.
    Blakebrough IS; Greenwood BM; Whittle HC; Bradley AK; Gilles HM
    J Infect Dis; 1982 Nov; 146(5):626-37. PubMed ID: 7130749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Norman epidemics: MenBvac vaccine].
    Floret D
    Arch Pediatr; 2007 Jun; 14(6):541-3. PubMed ID: 17446054
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningococcal disease in Africa.
    Hart CA; Cuevas LE
    Ann Trop Med Parasitol; 1997 Oct; 91(7):777-85. PubMed ID: 9625934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
    Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
    J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal disease.
    Memish ZA; Alrajhi AA
    Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci.
    Mäkelä PH; Peltola H
    Lancet; 1978 Oct; 2(8093):780-1. PubMed ID: 80699
    [No Abstract]   [Full Text] [Related]  

  • 18. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
    Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
    Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region.
    Soriano-Gabarró M; Wolter J; Hogea C; Vyse A
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):761-74. PubMed ID: 21905785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.